Boston Scientific restructuring plan will incur up to $800 M in pre‑tax charges as the company shifts production and cuts jobs to…
Prevent drug diversion with multidisciplinary auditing and procurement checks beyond diversion surveillance software effectively.
Sacituzumab govitecan is a new first-line treatment option for breast cancer patients with metastatic triple-negative breast cancer.
Cancer patients often blur lines between cancer care and everyday medical management, requiring adaptability from oncologists and primary care doctors in cancer
Learn about the nonnegotiable bispecific dose protocols for safe administration in community oncology practices, as outlined by pharmacy leaders and experts.
A new study shows voice biomarkers on smartphones can detect worsening asthma or COPD flare-ups early, potentially reducing emergency hospital visits.
Remote monitoring myasthenia study shows daily app tracking uncovers symptom swings missed in clinic visits, offering new insights for patient care.
The veligrotug trial reveals a 2.9 mm reduction in proptosis for thyroid eye disease patients, offering a new FDA‑approved option beyond teprotumumab.
Users report unexpected account blocks across platforms, prompting concerns about security and access; discover why these blocks happen and how to resolve…
Musculoskeletal toxicities, including myalgias and arthralgias, impact up to 40% of patients on BTK inhibitors with muscle and joint pain.